Title:
ANTI-LIV-1 ANTIBODY, DRUG CONJUGATE THEREOF, AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/109944
Kind Code:
A1
Abstract:
Provided are a LIV-1 binding molecule and a preparation method therefor, and a corresponding immunoconjugate, a pharmaceutical composition, a medical use, and a method for preventing a disease, in particular a method for treating cancer or a tumor.
More Like This:
Inventors:
DONG LIWEI (CN)
ZHANG WEI (CN)
CHEN SIMENG (CN)
WANG LILI (CN)
LIAO CHENG (CN)
ZHANG WEI (CN)
CHEN SIMENG (CN)
WANG LILI (CN)
LIAO CHENG (CN)
Application Number:
PCT/CN2023/134161
Publication Date:
May 30, 2024
Filing Date:
November 24, 2023
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI SHENGDI PHARMACEUTICAL CO LTD (CN)
SHANGHAI SHENGDI PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K39/395; C07K16/28; A61P35/00; C07K16/30; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/12; C12N15/13; C12N15/63
Foreign References:
CN103533957A | 2014-01-22 | |||
CN106999517A | 2017-08-01 | |||
CN114206933A | 2022-03-18 | |||
CN1849337A | 2006-10-18 | |||
US20040141983A1 | 2004-07-22 | |||
US20050175619A1 | 2005-08-11 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: